LifeStance Health price to book ratio LFST

Market value divided by the book value of the company's net assets, since 2021.

Today, Oct 23, 2026: 3.3×
5-year median: 1.8×
Against its 5-year history: 97th; percentile: 0 is its lowest day, 100 its highest
5-year range: 1.0× to 3.9×
Peer median: 5.5×

LifeStance Health's price to book ratio is 3.3× as of Oct 23, 2026.

That is above its 5-year median of 1.8×, higher than on 97% of days in the last 5 years.

Over that time it ranged from 1.0× in Aug 2025 to 3.9× in Sep 2021.

The median for 10 hospital and care facility stocks of a similar size is 5.5×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	3.3×	1.6×	3.4×
2025	1.9×	1.0×	2.1×
2024	2.0×	1.3×	2.1×
2023	2.0×	1.2×	2.3×
2022	1.2×	1.1×	2.7×
2021	2.3×	1.9×	3.9×

Against its peers

Companies in Medical - Care Facilities nearest LifeStance Health's size, closest first, today.

Company	Price to book ratio
LFSTLifeStance Health	3.3×
CONConcentra Group Holdings Parent	10.5×
SHCSotera Health	7.8×
OPCHOption Care Health	3.7×
NHCNational Healthcare	3.3×
CHEChemed	8.1×
PACSPACS	6.8×
AVAHAveanna Healthcare	10.2×
PRVAPrivia Health	3.7×
ENSGEnsign	4.2×
MDPediatrix Medical	2.7×
Peer median	5.5×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on LifeStance Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.